New report finds 15 new oncology therapies launched last year

A record 15 new oncology therapeutics launched in 2018 for 17 tumor types, according to IQVIA’s “Global Oncology Trends 2019” report. This progress includes a continued shift toward precision...
Read More
Clinical Trials Awareness Week: Celebrating innovation in clinical research

This week is Clinical Trials Awareness Week — an annual event to recognize the important role clinical trials play in helping develop safe and effective medicines.
Read More
Event: New era of medicine comes to Capitol Hill

Biopharmaceutical researchers work every day to translate science into new treatments and cures. This passion has led to breakthroughs like gene therapy to treat childhood blindness, ...
Read More
New report shows more than 160 medicines in development for diabetes and related conditions

Diabetes represents a significant public health issue in the U.S. It affects more than 30 million Americans, including around 7.2 million who are undiagnosed. Additionally, there are close to 1.5...
Read More
Minority health matters

April is National Minority Health Month, a time to recognize and raise awareness of health disparities that affect racial and ethnic minorities.
Read More
New report shows nearly 20 innovative medicines in development for sickle cell disease

Sickle cell disease (SCD) is the most common inherited blood disorder in the United States, afflicting nearly 100,000 Americans. Patients with SCD have sickle-shaped red blood cells, which have...
Read More
130 medicines in development for asthma, allergies and other respiratory diseases

Millions of Americans suffer from respiratory diseases, including Asthma and chronic obstructive pulmonary disease (COPD). Together, these two diseases affect the day-to-day lives of over 40...
Read More
Putting 2018 medicine approvals in context

Last year, the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) approved a record number of novel new medicines with 59 new molecular entities (NMEs). While...
Read More
Disrupting Alzheimer's

We are living in a new era of medicine, where treatments and even cures once believed to be impossible are today a reality. But this immense progress does not apply universally and there have been...
Read More
Aspen Spotlight Health: Discussing the forefront of innovation

For the second year in a row, PhRMA is proud to participate in Aspen’s Spotlight Health Conference. As the opening session of Aspen Ideas Festival, Spotlight Health welcomes over 1,500 experts and...
Read More